Phibro Animal Health (PAHC) Goodwill & Intangibles (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Goodwill & Intangibles of $91.6 million in Q1 2026, down 1.41% quarter-over-quarter from $92.9 million in Q4 2025, and down 0.83% on a YoY basis from $92.3 million in Q1 2025.
Phibro Animal Health (PAHC) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Phibro Animal Health's Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $91.6 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 0.83% year-over-year to $91.6 million; the TTM figure through Mar 2026 stood at $91.6 million (down 0.83% YoY), while the FY2025 annual figure was $96.1 million, down 3.49% from the prior year.
- Goodwill & Intangibles was $91.6 million for Q1 2026 at Phibro Animal Health, down from $92.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $203.2 million in Q2 2023 to a low of $91.6 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $113.8 million across 5 years, with a median of $102.9 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 75.2% in 2022, then tumbled 51.0% in 2024.
- A 5-year view of Goodwill & Intangibles shows it stood at $112.3 million in 2022, then dropped by 5.92% to $105.6 million in 2023, then retreated by 10.6% to $94.4 million in 2024, then slipped by 1.65% to $92.9 million in 2025, then retreated by 1.41% to $91.6 million in 2026.
- The last three Goodwill & Intangibles figures came in at $91.6 million (Q1 2026), $92.9 million (Q4 2025), and $94.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.57 Mn |
| Dec 31, 2025 | 92.88 Mn |
| Sep 30, 2025 | 94.67 Mn |
| Jun 30, 2025 | 96.11 Mn |
| Mar 31, 2025 | 92.34 Mn |
| Dec 31, 2024 | 94.44 Mn |
| Sep 30, 2024 | 97.52 Mn |
| Jun 30, 2024 | 99.59 Mn |
| Mar 31, 2024 | 102.88 Mn |
| Dec 31, 2023 | 105.65 Mn |
| Sep 30, 2023 | 105.44 Mn |
| Jun 30, 2023 | 203.25 Mn |
| Mar 31, 2023 | 110.14 Mn |
| Dec 31, 2022 | 112.29 Mn |
| Sep 30, 2022 | 114.34 Mn |
| Jun 30, 2022 | 201.42 Mn |
| Mar 31, 2022 | 120.71 Mn |
| Dec 31, 2021 | 110.65 Mn |
| Sep 30, 2021 | 112.80 Mn |
| Jun 30, 2021 | 114.96 Mn |